Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival

Advances in Oto-Rhino-Laryngology

Volumn 62, Issue , 2005, Pages 72-80

  Wittekindt, Claus ^a,c   Gültekin, Elif ^b   Weissenborn, Soenke J ^a   Dienes, Hans P ^a   Pfister, Herbert J ^a   Klussmann, Jens P ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b GAZI UNIVERSITY   (Turkey)

^c Department of Otolaryngology Head and Neck Surgery   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16INK4A; TUMOR MARKER; VIRUS DNA;

ARTICLE; CASE CONTROL STUDY; CELL TRANSFORMATION; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; MALE; METABOLISM; MORTALITY; NEEDLE BIOPSY; PAPILLOMA VIRUS; PATHOLOGY; PROBABILITY; PROGNOSIS; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; SURVIVAL; TONSIL TUMOR; VIROLOGY; VIRUS INFECTION;

BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROBABILITY; PROGNOSIS; REFERENCE VALUES; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TONSILLAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 16644381706     PISSN: 00653071     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (30)

1. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-440.
2. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-707.
3. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753-756.
4. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G: Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996;16:859-867.
5. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel DM: Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-284.
6. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T: Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int 1998;48:580-585.
7. zur Hausen H: Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2002;2:342-350.
8. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J, Sidransky D: High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996;56:3630-3633.
9. Poi MJ, Yen T, Li J, Song H, Lang JC, Schuller DE, Pearl DK, Casto BC, Tsai MD, Weghorst CM: Somatic INK4a-ARF locus mutations: A significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck. Mol Carcinog 2001;30:26-36.
10. El Naggar AK, Lai S, Clayman G, Lee JK, Luna MA, Goepfert H, Batsakis JG: Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am J Pathol 1997;151:1767-1774.
11. Gruttgen A, Reichenzeller M, Junger M, Schlien S, Affolter A, Bosch FX: Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers. J Pathol 2001;194:311-317.
12. Ambrosch P, Schlott T, Hilmes D, Ruschenburg I: p16 alterations and retinoblastoma protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract. Virchows Arch 2001;438:343-349.
13. 1 amplification and p16 (MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 2002;112:472-481.
14. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV Sidransky D: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-720.
15. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344:1125-1131.
16. Klussmann JP, Weissenborn S, Wieland U, Dries V, Kolligs J, Jungehuelsing M, Eckel HE, Dienes HP, Pfister H, Fuchs P: Prevalence, distribution and viral load of human papillomavirus 16 DNA In tonsillar carcinomas. Cancer 2001;92:2875-2884.
17. Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, Turek LP, Haugen TH: Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003;104:336-344.
18. Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Hoffman HT, Wang D, Haugen TH, Turek LP: Risks associated with human papillomavirus infection in oral cavity and oropharynx. Int J Cancer 2004;108:776-772.
19. Klussmann JP, Gultekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, Eckel HE, Pfister HJ, Fuchs PG: Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003;162:747-753.
20. Hafkamp HC, Speel EJ, Haesevoets A, Bot FJ, Dinjens WN, Ramaekers FC, Hopman AH, Manni JJ: A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 2003;107:394-400.
21. Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Eckel HE, Pfister HJ, Fuchs PG: Human papillomavirus-positive tonsillar carcinomas: A different tumor entity? Med Microbiol Immunol (Berl) 2003;192:129-132.
22. Greene FL, Page DL, Fleming ID, Fritz AG, Blach CM, Haller DG, Morrow M: American Joint Committee on Cancer Staging Manual, ed 6. Berlin, Springer, 2002.
23. Forastiere A, Koch W, Trotti A, Sidransky D: Head and neck cancer. N Engl J Med 2001;345:1890-1900.
24. Strome SE, Savva A, Brissett AE, Gostout BS, Lewis J, Clayton AC, McGovern R, Weaver AL, Persing D, Kasperbauer JL: Squamous cell carcinoma of the tonsils: A molecular analysis of HPV associations. Clin Cancer Res 2002;8:1093-1100.
25. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, Fernandez L, Idris A, Sanchez MJ, Nieto A, Talamini R, Tavani A, Bosch FX, Reidel U, Snijders PJ, Meijer CJ, Viscidi R, Munoz N, Franceschi S: Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003;95:1772-1783.
26. Klussmann JP, Weissenborn S, Fuchs PG: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;345:376.
27. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM: Human papillomavirus positive squamous cell carcinoma of the oropharynx: A radiosensitive subgroup of head and neck carcinoma. Cancer 2001;92:805-813.
28. van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F, Smeele LE, Snow GB, Brakenhoff RH: Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001;93:232-235.
29. Balz V, Scheckenbach K, Gotte K, Bockmuhl U, Petersen I, Bier H: Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. Cancer Res 2003;63:1188-1191.
30. Peltenburg LT: Radiosensitivity of tumor cells: Oncogenes and apoptosis. Q J Nucl Med 2000;44:355-364.